ANDA 90063, held by Mylan Pharma. Levofloxacin.
As of Nov 16, 2026, ANDA 90063 (Levofloxacin), held by Mylan Pharma, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 4, 2009 | Original application | Tentative approval | None posted |
| Levofloxacin250MG · tablet; oral | Levofloxacin | None (tentative approval) |
| Levofloxacin500MG · tablet; oral | Levofloxacin | None (tentative approval) |
| Levofloxacin750MG · tablet; oral | Levofloxacin | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters